NCT00328172 - Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients | Biotech Hunter

Enrollment

302

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2007

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Placebo

Placebo matching BI 1356

DRUG

BI 1356 dose 3 once daily

DRUG

BI 1356 dose 2 once daily

DRUG

BI 1356 dose 1 once daily

DRUG

Metformin

Trial Locations (71)

Unknown

1218.5.10020 Boehringer Ingelheim Investigational Site, Chula Vista

1218.5.10001 Boehringer Ingelheim Investigational Site, La Jolla

1218.5.10007 Boehringer Ingelheim Investigational Site, Walnut Creek

1218.5.10041 Boehringer Ingelheim Investigational Site, Denver

1218.5.10018 Boehringer Ingelheim Investigational Site, Hollywood

1218.5.10016 Boehringer Ingelheim Investigational Site, Jacksonville

1218.5.10003 Boehringer Ingelheim Investigational Site, Miami

1218.5.10011 Boehringer Ingelheim Investigational Site, Miami

1218.5.10012 Boehringer Ingelheim Investigational Site, Orlando

1218.5.10017 Boehringer Ingelheim Investigational Site, Indianapolis

1218.5.10008 Boehringer Ingelheim Investigational Site, Topeka

1218.5.10024 Boehringer Ingelheim Investigational Site, Wichita

1218.5.10039 Boehringer Ingelheim Investigational Site, Baltimore

1218.5.10032 Boehringer Ingelheim Investigational Site, Springfield

1218.5.10025 Boehringer Ingelheim Investigational Site, Chesterfield

1218.5.10034 Boehringer Ingelheim Investigational Site, Butte

1218.5.10009 Boehringer Ingelheim Investigational Site, Omaha

1218.5.10042 Boehringer Ingelheim Investigational Site, Albany

1218.5.10029 Boehringer Ingelheim Investigational Site, Endwell

1218.5.10004 Boehringer Ingelheim Investigational Site, New Hyde Park

1218.5.10026 Boehringer Ingelheim Investigational Site, Columbus

1218.5.10035 Boehringer Ingelheim Investigational Site, Mentor

1218.5.10023 Boehringer Ingelheim Investigational Site, Medford

1218.5.10030 Boehringer Ingelheim Investigational Site, Philadelphia

1218.5.10044 Boehringer Ingelheim Investigational Site, Columbia

1218.5.10033 Boehringer Ingelheim Investigational Site, Greer

1218.5.10038 Boehringer Ingelheim Investigational Site, Simpsonville

1218.5.10006 Boehringer Ingelheim Investigational Site, Dallas

1218.5.10040 Boehringer Ingelheim Investigational Site, Houston

1218.5.10036 Boehringer Ingelheim Investigational Site, San Antonio

1218.5.10021 Boehringer Ingelheim Investigational Site, Tyler

1218.5.10027 Boehringer Ingelheim Investigational Site, Salem

1218.5.10022 Boehringer Ingelheim Investigational Site, Federal Way

1218.5.10014 Boehringer Ingelheim Investigational Site, Renton

1218.5.61001 Boehringer Ingelheim Investigational Site, Miranda

1218.5.61005 Boehringer Ingelheim Investigational Site, Box Hill

1218.5.61006 Boehringer Ingelheim Investigational Site, Dandenong

1218.5.61007 Boehringer Ingelheim Investigational Site, East Ringwood

1218.5.61004 Boehringer Ingelheim Investigational Site, Fremantle

1218.5.61002 Boehringer Ingelheim Investigational Site, Nedlands

1218.5.11011 Boehringer Ingelheim Investigational Site, Calgary

1218.5.11016 Boehringer Ingelheim Investigational Site, Calgary

1218.5.11003 Boehringer Ingelheim Investigational Site, Red Deer

1218.5.11004 Boehringer Ingelheim Investigational Site, Vancouver

1218.5.11013 Boehringer Ingelheim Investigational Site, Vancouver

1218.5.11015 Boehringer Ingelheim Investigational Site, Winnipeg

1218.5.11005 Boehringer Ingelheim Investigational Site, Hamilton

1218.5.11014 Boehringer Ingelheim Investigational Site, Oakville

1218.5.11010 Boehringer Ingelheim Investigational Site, Ottawa

1218.5.11009 Boehringer Ingelheim Investigational Site, Sarnia

1218.5.11012 Boehringer Ingelheim Investigational Site, Thornhill

1218.5.11002 Boehringer Ingelheim Investigational Site, Toronto

1218.5.11006 Boehringer Ingelheim Investigational Site, Montague

1218.5.11017 Boehringer Ingelheim Investigational Site, Sainte-Foy

1218.5.11018 Boehringer Ingelheim Investigational Site, Saskatoon

1218.5.42002 Boehringer Ingelheim Investigational Site, Olomouc

1218.5.42003 Boehringer Ingelheim Investigational Site, Prague

1218.5.42004 Boehringer Ingelheim Investigational Site, Prague

1218.5.42005 Boehringer Ingelheim Investigational Site, Prague

1218.5.42001 Boehringer Ingelheim Investigational Site, Sternberk

1218.5.70001 Boehringer Ingelheim Investigational Site, Moscow

1218.5.70002 Boehringer Ingelheim Investigational Site, Moscow

1218.5.70003 Boehringer Ingelheim Investigational Site, Moscow

1218.5.70004 Boehringer Ingelheim Investigational Site, Saint Petersburg

1218.5.70005 Boehringer Ingelheim Investigational Site, Saint Petersburg

1218.5.38005 Boehringer Ingelheim Investigational Site, Kharkiv

1218.5.38001 Boehringer Ingelheim Investigational Site, Kiev

1218.5.38002 Boehringer Ingelheim Investigational Site, Kiev

1218.5.38003 Boehringer Ingelheim Investigational Site, Kiev

1218.5.38004 Boehringer Ingelheim Investigational Site, Lviv

1218.5.38006 Boehringer Ingelheim Investigational Site, Vinnitsa